These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29329538)

  • 1. Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular events.
    Wingrove JA; Fitch K; Rhees B; Rosenberg S; Voora D
    BMC Med Genomics; 2018 Jan; 11(1):1. PubMed ID: 29329538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
    Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR).
    Pamukcu B; Oflaz H; Onur I; Oncul A; Ozcan M; Umman B; Mercanoglu F; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):187-92. PubMed ID: 17287637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM
    JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet turnover predicts outcome after coronary intervention.
    Freynhofer MK; Iliev L; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Huber K
    Thromb Haemost; 2017 May; 117(5):923-933. PubMed ID: 28229159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.
    Pamukcu B; Oflaz H; Oncul A; Umman B; Mercanoglu F; Ozcan M; Meric M; Nisanci Y
    J Thromb Thrombolysis; 2006 Oct; 22(2):103-10. PubMed ID: 17008975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Christie DJ; Kottke-Marchant K; Gorman RT
    Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
    Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
    Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease.
    Cao J; Liu L; Fan L; Chen T; Hu G; Hu Y; Zhu B; Li J; Wang H; Li X
    Aging Male; 2012 Sep; 15(3):140-7. PubMed ID: 22452804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.
    Lacaze P; Bakshi A; Riaz M; Polekhina G; Owen A; Bhatia HS; Natarajan P; Wolfe R; Beilin L; Nicholls SJ; Watts GF; McNeil JJ; Tonkin AM; Tsimikas S
    J Am Coll Cardiol; 2022 Oct; 80(14):1287-1298. PubMed ID: 36175048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of immature platelets with adverse cardiovascular outcomes.
    Ibrahim H; Schutt RC; Hannawi B; DeLao T; Barker CM; Kleiman NS
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2122-9. PubMed ID: 25457402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical prediction rule to estimate the absolute 3-year risk of major cardiovascular events after carotid endarterectomy.
    van Lammeren GW; Catanzariti LM; Peelen LM; de Vries JP; de Kleijn DP; Moll FL; Pasterkamp G; Bots ML
    Stroke; 2012 May; 43(5):1273-8. PubMed ID: 22442175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials.
    Ware JH; Vetrovec GW; Miller AB; Van Tosh A; Gaffney M; Yunis C; Arteaga C; Borer JS
    Am J Ther; 2013; 20(3):235-46. PubMed ID: 23615317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events.
    Davila CD; Vargas F; Huang KH; Monaco T; Dimou A; Rangaswami J; Figueredo VM
    Platelets; 2015; 26(7):651-6. PubMed ID: 25354134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.
    Solomon DH; Libby P; Yeomans ND; Wang Q; Wolski KE; Nissen SE; Husni ME
    Rheumatology (Oxford); 2018 Aug; 57(8):1364-1369. PubMed ID: 29688503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.